Molecular profiling ofMycobacterium tuberculosisidentifies tuberculosinyl nucleoside products of the virulence-associated enzyme Rv3378c

Proceedings of the National Academy of Sciences
2014.0

Abstract

<jats:title>Significance</jats:title><jats:p>Whereas most mycobacteria do not cause disease,<jats:italic>Mycobacterium tuberculosis</jats:italic>kills more than one million people each year. To better understand why<jats:italic>Mycobacterium tuberculosis</jats:italic>is virulent and to discover chemical markers of this pathogen, we compare its lipid profile with that of the attenuated but related mycobacterium,<jats:italic>Mycobacterium bovis</jats:italic>Bacillus Calmette–Guérin. This strategy identified a previously unknown<jats:italic>Mycobacterium tuberculosis</jats:italic>-specific lipid, 1-tuberculosinyladenosine, which is produced by the Rv3378c enzyme. The crystal structure of Rv3378c provides information supporting drug design to inhibit prenyl transfer. Discovery of 1-tuberculosinyladenosine provides insight into how<jats:italic>Mycobacterium tuberculosis</jats:italic>resists killing in macrophages and a new target for diagnosing tuberculosis disease.

Knowledge Graph

Similar Paper

Molecular profiling of<i>Mycobacterium tuberculosis</i>identifies tuberculosinyl nucleoside products of the virulence-associated enzyme Rv3378c
Proceedings of the National Academy of Sciences 2014.0
In Vivo Biosynthesis of Terpene Nucleosides Provides Unique Chemical Markers of Mycobacterium tuberculosis Infection
Chemistry &amp; Biology 2015.0
Rationally Designed Nucleoside Antibiotics That Inhibit Siderophore Biosynthesis of Mycobacterium tuberculosis
Journal of Medicinal Chemistry 2006.0
Antitubercular Nucleosides That Inhibit Siderophore Biosynthesis:  SAR of the Glycosyl Domain
Journal of Medicinal Chemistry 2006.0
Asymmetric synthesis and structure elucidation of a glycerophospholipid from Mycobacterium tuberculosis
Journal of Lipid Research 2010.0
The Mur Enzymes Chink in the Armour of Mycobacterium tuberculosis cell wall
European Journal of Medicinal Chemistry 2021.0
Lipolytic enzymes inhibitors: A new way for antibacterial drugs discovery
European Journal of Medicinal Chemistry 2021.0
Discovery of the first Mycobacterium tuberculosis MabA (FabG1) inhibitors through a fragment-based screening
European Journal of Medicinal Chemistry 2020.0
Evaluation of NTF1836 as an inhibitor of the mycothiol biosynthetic enzyme MshC in growing and non-replicating Mycobacterium tuberculosis
Bioorganic &amp; Medicinal Chemistry 2011.0
Carbonic anhydrase inhibitors. Inhibition of the Rv1284 and Rv3273 β-carbonic anhydrases from Mycobacterium tuberculosis with diazenylbenzenesulfonamides
Bioorganic &amp; Medicinal Chemistry Letters 2009.0